ES2125879T3 - Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central. - Google Patents

Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central.

Info

Publication number
ES2125879T3
ES2125879T3 ES92117606T ES92117606T ES2125879T3 ES 2125879 T3 ES2125879 T3 ES 2125879T3 ES 92117606 T ES92117606 T ES 92117606T ES 92117606 T ES92117606 T ES 92117606T ES 2125879 T3 ES2125879 T3 ES 2125879T3
Authority
ES
Spain
Prior art keywords
nervous system
central nervous
triazaespirodecanone
methychromanes
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117606T
Other languages
English (en)
Inventor
Hans-Georg Dr Heine
Rudolf Dr Schohe-Loop
Thomas Dr Glaser
Vry Jean Marie Viktor Dr De
Wolfgang Dr Dompert
Henning Dr Sommermeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2125879T3 publication Critical patent/ES2125879T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

SE FABRICA TRIAZASPIRODECANON LA GENERAL (I), EN DONDE LOS METILCROMANOS, QUE SON SUSTITUIDOS EN EL GRUPO METIL POR MEDIO DE LOS CORRESPONDIENTES GRUPOS DE SALIDA SE TRANSFORMAN CON TRIAZASPIRODECANONENOS. LAS SUSTANCIAS PUEDEN SER UTILIZADAS PARA LA FABRICACION DE MEDICAMENTOS, EN PARTICULAR PARA MEDICAMENTOS PARA LA LUCHA CONTRA LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL.
ES92117606T 1991-10-28 1992-10-15 Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central. Expired - Lifetime ES2125879T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (1)

Publication Number Publication Date
ES2125879T3 true ES2125879T3 (es) 1999-03-16

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117606T Expired - Lifetime ES2125879T3 (es) 1991-10-28 1992-10-15 Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central.

Country Status (19)

Country Link
US (1) US6060482A (es)
EP (1) EP0539803B1 (es)
JP (1) JP3257708B2 (es)
KR (1) KR930007945A (es)
AT (1) ATE175414T1 (es)
AU (1) AU650792B2 (es)
CA (1) CA2081256A1 (es)
CZ (1) CZ322492A3 (es)
DE (2) DE4135473A1 (es)
DK (1) DK0539803T3 (es)
ES (1) ES2125879T3 (es)
FI (1) FI924848A (es)
GR (1) GR3029450T3 (es)
HU (1) HUT64068A (es)
IL (1) IL103546A0 (es)
MX (1) MX9205869A (es)
NO (1) NO923974L (es)
TW (1) TW208010B (es)
ZA (1) ZA928290B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
JP3989247B2 (ja) * 1999-12-06 2007-10-10 ユーロ−セルティーク エス．エイ． ノシセプチン受容体親和性を有するトリアゾスピロ化合物
EP1445324A4 (en) * 2001-11-09 2005-02-16 Kaneka Corp PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE PRODUCT
US6995168B2 (en) 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
CN100402529C (zh) * 2002-09-09 2008-07-16 詹森药业有限公司 用于治疗orl-1受体介导疾病的羟基烷基取代的1,3,8-三氮杂螺[4,5]癸-4-酮衍生物
WO2005036104A1 (en) * 2003-10-16 2005-04-21 Collier William R Fluid level detector and alarm apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
JP5727139B2 (ja) * 2006-11-28 2015-06-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ ３−（３−アミノ−２−（ｒ）−ヒドロキシ−プロピル）−１−（４−フルオロ−フェニル）−８−（８−メチル−ナフタレン−１−イルメチル）−１，３，８−トリアザ−スピロ［４．５］デカン−４−オンの塩
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
DK0539803T3 (da) 1999-08-30
NO923974D0 (no) 1992-10-13
CZ322492A3 (en) 1993-07-14
AU650792B2 (en) 1994-06-30
HUT64068A (en) 1993-11-29
DE4135473A1 (de) 1993-04-29
FI924848A (fi) 1993-04-29
KR930007945A (ko) 1993-05-20
GR3029450T3 (en) 1999-05-28
TW208010B (es) 1993-06-21
DE59209607D1 (de) 1999-02-18
EP0539803A1 (de) 1993-05-05
CA2081256A1 (en) 1993-04-29
ZA928290B (en) 1993-05-04
NO923974L (no) 1993-04-29
US6060482A (en) 2000-05-09
EP0539803B1 (de) 1999-01-07
AU2626592A (en) 1993-04-29
JPH05222040A (ja) 1993-08-31
IL103546A0 (en) 1993-03-15
HU9203382D0 (en) 1993-01-28
MX9205869A (es) 1993-04-01
ATE175414T1 (de) 1999-01-15
FI924848A0 (fi) 1992-10-26
JP3257708B2 (ja) 2002-02-18

Similar Documents

Publication Publication Date Title
ES2086623T3 (es) Azaheterociclilmetil-cromanos como principios activos para el tratamiento de enfermedades del sistema nervioso central.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
FI942074A (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
SV2002000169A (es) Nuevos derivados del acido aminodicarboxilico con propiedades farmaceuticas ref. lea 33878-sv
ES2154266T3 (es) Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico y su empleo como medicamentos.
ES2125879T3 (es) Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central.
SE8307119L (sv) Karboxylsyraamider och derivat derav
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
ES2087407T3 (es) Derivados de cromano sustituido con piperidilmetilo como principio activo para el tratamiento de enfermedades del sistema nervioso central.
ES2134284T3 (es) Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.
MX9300638A (es) Derivados del acido aminobenzoico.
ES2078101T3 (es) Derivados de flavona.
IT1258788B (it) Derivati solforati di acidi biliari
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
DE3580173D1 (de) Verbindungen mit antibakterieller wirksamkeit, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
PT746556E (pt) Compostos triciclicos com afinidade para o receptor 5-ht1a
NO933465L (no) Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling
ITMI912988A1 (it) Composizioni farmaceutiche ad uso orale, a base di esteri interni di gangliosidi, per il trattamento di patologie del sistema nervoso centrale
ES481243A0 (es) Procedimiento para cultivo del parral y similares por el sistema de capillas adosadas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539803

Country of ref document: ES